Cite

HARVARD Citation

    Richard, G. et al. (n.d.). 58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer. Journal for immunotherapy of cancer. p. A37. [Online]. 
  
Back to record